phys.org
Glycopeptide probes detect pancreatic-tumor-associated antibodies in blood samples
Pancreatic cancer is one of the most lethal forms of cancer, primarily because it is usually diagnosed very late. Current markers are too insensitive and unspecific for early detection screenings. In the journal Angewandte Chemie, a research team has now introduced a new method that could lead to a significantly more precise and reliable diagnosis. It is based on the selective detection of specific antibodies in blood samples.
New Posts (Home)
ChatBox
Popular Posts 
Game Zone
Top PodCasts
